স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - etinilestradiol, gestoden - tableta - etinilestradiol 0,02 mg / 1 tableta; gestoden 0,075 mg / 1 tableta - gestoden in etinilestradiol

স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - etinilestradiol, gestoden - tableta - etinilestradiol 0,03 mg / 1 tableta; gestoden 0,075 mg / 1 tableta - gestoden in etinilestradiol

স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

teva pharma b.v. - dezogestrel - filmsko obložena tableta - dezogestrel 75 µg / 1 tableta - dezogestrel

স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bayer d.o.o. - noretisteronacetat - tableta - noretisteronacetat 5 mg / 1 tableta - noretisteron

স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan s.a.s. - sildenafil - filmsko obložena tableta - sildenafil 50 mg / 1 tableta - sildenafil

স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan s.a.s. - sildenafil - filmsko obložena tableta - sildenafil 100 mg / 1 tableta - sildenafil

স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stada arzneimittel ag - sildenafil - filmsko obložena tableta - sildenafil 20 mg / 1 tableta - sildenafil

স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gedeon richter plc. - drospirenon; etinilestradiol - filmsko obložena tableta - drospirenon 3 mg / 1 tableta  etinilestradiol0,03 mg / 1 tableta; etinilestradiol 0,03 mg / 1 tableta - drospirenon in etinilestradiol

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

eli lilly nederland b.v. - tadalafil - hipertenzija, pljučnica - urološki - adultstreatment of pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity (see section 5. učinkovitost so pokazali pri idiopatskem pah (ipah) in pri pah, povezani s kolagensko vaskularno boleznijo. paediatric populationtreatment of paediatric patients aged 2 years and above with pulmonary arterial hypertension (pah) classified as who functional class ii and iii.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

bayer ag - riociguat - hipertenzija, pljučnica - antihipertenzivi za pljučno arterijsko hipertenzijo - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. učinkovitosti je bil prikazan v pah prebivalstva, vključno z aetiologies z idiopatsko ali dedne pah ali pah, povezanih z vezivnega tkiva bolezni. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.